Cargando…
Epigallocatechin-3-gallate alleviates type 2 diabetes mellitus via β-cell function improvement and insulin resistance reduction
OBJECTIVE(S): Epigallocatechin-3-gallate (EGCG) has a good therapeutic effect on type 2 diabetes mellitus (T2DM). This work was designed to explore EGCG’s effectiveness in insulin resistance (IR) and pancreas islet β-cell function in a rat model of T2DM. MATERIALS AND METHODS: Eight-week-old male Sp...
Autores principales: | Zhu, Tiantian, Li, Minghui, Zhu, Moli, Liu, Xu, Huang, Keke, Li, Wenru, Wang, Shuang-Xi, Yin, Yaling, Li, Peng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Mashhad University of Medical Sciences
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9150804/ https://www.ncbi.nlm.nih.gov/pubmed/35656076 http://dx.doi.org/10.22038/IJBMS.2022.58591.13016 |
Ejemplares similares
-
Epigallocatechin-3-gallate ameliorates glucolipid metabolism and oxidative stress in type 2 diabetic rats
por: Li, Wenru, et al.
Publicado: (2020) -
Bioaccessibility and Bioavailability of (-)-Epigallocatechin Gallate in the Bread Matrix with Glycemic Reduction
por: Li, Lanqi, et al.
Publicado: (2022) -
Effects of epigallocatechin-3-gallate combined with ascorbic acid and glycerol on the stability and uric acid-lowering activity of epigallocatechin-3-gallate
por: Xie, Qianjin, et al.
Publicado: (2021) -
Role of Epigallocatechin Gallate in Glucose, Lipid, and Protein Metabolism and L-Theanine in the Metabolism-Regulatory Effects of Epigallocatechin Gallate
por: Lin, Ling, et al.
Publicado: (2021) -
RNA-seq profiling of white and brown adipocyte differentiation treated with epigallocatechin gallate
por: Zhang, Pengpeng, et al.
Publicado: (2022)